Cognitive Behavioral Therapy Reduces Benzodiazepine Anxiolytics Use in Japanese Patients with Mood and Anxiety Disorders: A Retrospective Observational Study

PURPOSE: Benzodiazepines (BZDs) are prescribed to treat psychiatric diseases. However, many guidelines recommend limiting the use of BZDs because of side effects and lack of evidence regarding long-term efficacy. Moreover, reducing BZDs’ use is difficult because of dependency and the severity of wit...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Neuropsychiatr Dis Treat
Main Authors: Nakajima, Aiichiro, Kanie, Ayako, Ito, Masaya, Hirabayashi, Naotsugu, Imamura, Fumi, Takebayashi, Yoshitake, Horikoshi, Masaru
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove 2020
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509325/
https://ncbi.nlm.nih.gov/pubmed/32982251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S263537
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים